论文部分内容阅读
研究背景:前列腺癌是西方国家男性最常见的非皮肤来源恶性肿瘤,病死率排第二位。根治性前列腺切除(RP)是临床局限性前列腺癌标准的外科治疗手段。然而,术后病理诊断发现肿瘤侵出前列腺包膜(pT3)或者切缘阳性(R1)的患者预后不佳,5年生化疾病进展率高达67%。目前接受RP手
Background: Prostate cancer is the most common non-skin cancer in men in Western countries, with the second highest mortality rate. Radical prostatectomy (RP) is a standard surgical treatment of clinically localized prostate cancer. However, postoperative pathologic findings showed poor prognosis in patients with tumor invasion of the prostate capsule (pT3) or positive margins (R1), with a 5-year biochemical disease progression rate of 67%. Currently accept the RP hand